TRUADVICE’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$934K Buy
44,458
+29,077
+189% +$551K 0.37% 77
2023
Q2
$292K Buy
15,381
+1,081
+8% +$21.8K 0.11% 185
2023
Q1
$300K Buy
14,300
+813
+6% +$16.4K 0.12% 174
2022
Q4
$272K Sell
13,487
-469
-3% -$9.72K 0.14% 134
2022
Q3
$289K Sell
13,956
-561
-4% -$11.2K 0.16% 111
2022
Q2
$278K Sell
14,517
-5,035
-26% -$102K 0.15% 124
2022
Q1
$384K Sell
19,552
-1,847
-9% -$34K 0.21% 90
2021
Q4
$391K Buy
21,399
+530
+3% +$9K 0.37% 81
2021
Q3
$338K Sell
20,869
-54,682
-72% -$938K 0.31% 88
2021
Q2
$1.3M Buy
75,551
+6,277
+9% +$106K 0.28% 86
2021
Q1
$1.16M Buy
69,274
+15,500
+29% +$278K 0.34% 68
2020
Q4
$1.05M Buy
53,774
+17,650
+49% +$369K 0.32% 76
2020
Q3
$825K Buy
+36,124
New +$865K 0.34% 71

Other funds holding BTAL

TRUADVICE's BTAL Position: Q3 2023 in Review

TRUADVICE increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 189% in Q3 2023, buying an estimated $551K and bringing the position to 44,458 shares worth $934K. The position accounts for 0.37% of the portfolio, ranked #77.

TRUADVICE first reported a position in BTAL in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.3M in Q2 2021. 76 funds tracked by Wall St. Rank hold BTAL as of Q3 2023.

  • TRUADVICE held 44,458 shares of AGF US Market Neutral Anti-Beta Fund worth $934K as of Q3 2023.
  • TRUADVICE bought 29,077 AGF US Market Neutral Anti-Beta Fund shares in Q3 2023, an estimated $551K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.37% of TRUADVICE's portfolio in Q3 2023, its #77 holding.
  • TRUADVICE first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2020 and has held it in 13 quarters since.
  • TRUADVICE's AGF US Market Neutral Anti-Beta Fund position peaked at $1.3M in Q2 2021.
  • 76 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.